First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of ARV-102, a PROTAC LRRK2 degrader, in healthy volunteers
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-07-01 09:59:04 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1016/j.parkreldis.2025.107624
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1353802025003657
其他信息:
出版社: Elsevier BV
作者: L. Smits; Y. Zhang; C. Woodward; S. Aksenov; A.L. Zaninotto; C. Donnelly; T. Storz; Y. Folami; C. Lubeski; M. MacDougall; K. Kelly; A. Hendricson; S. Korsten; P. Kremer; A. Cacace

